Abstract
Since immunotherapy provides an opportunity to treat metastatic and disseminated tumors, it has become a major treatment strategy for cancer. However, current cancer immunotherapeutics have often exhibited insufficient practical outcomes, primarily attributed to inefficient delivery of tumor-associated antigens to elicit anticancer immunity. To achieve improved therapeutic efficacy, numerous efforts have been made to harness biomaterials for the targeted or sustained delivery of tumor-associated antigens to antigen-presenting cells. In this review, we highlight recent advances in the development of biomaterials to deliver tumor-associated antigens and their therapeutic potential for cancer treatment.[Figure not available: see fulltext.].
| Original language | English |
|---|---|
| Pages (from-to) | 834-842 |
| Number of pages | 9 |
| Journal | Macromolecular Research |
| Volume | 29 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- antigen delivery
- biomaterials
- cancer immunotherapy
Fingerprint
Dive into the research topics of 'Biomaterials as Antigen Delivery Carrier for Cancer Immunotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver